- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03463538
Hydrodilatation Versus Arthroscopic Capsular Release for Frozen Shoulder
A Randomised Control Trial of Arthroscopic Capsular Release Versus Hydrodilatation for Primary Adhesive Capsulitis of the Shoulder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All potential participants for this study will be identified by an Orthopaedic Shoulder Consultant in the shoulder clinics run at the Royal Devon and Exeter NHS trust. The patients will be screened for eligibility by a research associate (SG). The eligibility criteria will be that the patient is medically fit for an operation, and has severe primary frozen shoulder in the acute painful stage, that is deemed suitable for intervention by the consultant surgeon. The patients will be informed verbally and in writing about the trial by the research associate and informed consent will be taken.
The participating patients will be randomised in a 1:1 allocation to arthroscopic capsular release (ACR) or hydrodilatation (HD). The randomisation will be administered by a central independent randomisation service, provided by a medical secretary using a computer generated randomisation sequence, who is completely independent of the trial.
All patients will be asked to fill out a number of questionnaires prior to surgery: the Oxford Shoulder Score (OSS) and the EQ-5D. The range of movement within the shoulder joint will be documented in a standard fashion.
Each patient will then undergo the assigned procedure according to the randomisation. The ACR would be performed by one of the Consultant Shoulder surgeons in their standard manner. The Hydro-dilatation would be performed by one of the Consultant Musculoskeletal radiologists in their standard manner. This would ensure that the options at each step of the operation or procedure, such as patient positioning, approach to the shoulder joint, and the closure of the wound etc are left entirely to the discretion of the Consultant performing the procedure. This will ensure that the results of the trial can be generalised to as wide a group of patients and surgeons as possible.
After the operation, patients will be reviewed using the range of movement, OSS, a patient satisfaction score and EQ-5D at 6 weeks, 3 months, and 6 months post-operatively. A record will be kept of any complications associated with the treatment. This data will be collected with by the research associate, who is independent of either intervention.
The main analysis will investigate differences in the primary outcome measure the OSS, between the two treatment groups (ACR and HD) on an intention-to-treat basis, at 6 months post-operation. Secondary outcome measures will be analysed in a similar manner. Statistical analysis will be undertaken by a statistician blinded to the interventions. Advice will be sought from an independent statistician provided by the trust to confirm the statistical methodology.
The economic evaluation will investigate the comparative cost-effectiveness of ACR versus HD. Health outcomes within 6 months follow-up will be assessed using the EuroQoL data collected within the trial, which will be valued using the standard UK TTO tariff to produce Quality-Adjusted Life-Year (QALY) estimates.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Devon
-
Exeter, Devon, United Kingdom
- Royal Devon and Exeter Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Medically fit for an operation; normal x-ray; Codmans criteria frozen shoulder
Exclusion Criteria:
- Secondary causes of frozen shoulder; rotator cuff tears found at arthroscopy or hydro-dilatation; unable to adhere to trial protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Arthroscopic capsular release
Surgical release performed under general anesthetic
|
surgical release of shoulder joint capsule
|
Active Comparator: Hydro-dilatation
injection of water under local anesthetic in to shoulder joint
|
dilatation of shoulder joint capsule using water pressure under local anesthetic
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxford shoulder score
Time Frame: at 6months
|
Patient reported outcome with a maximum score of 48 and minimum of 0. 48 being the best outcome.
Comprises 12 questions relating to pain and function specific to the shoulder
|
at 6months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual analogue score
Time Frame: at 6 months
|
pain score from 0 to 10 marked by patient on a continuous line.
0 being the worst score
|
at 6 months
|
clinical assessment of range of movement (external rotation, internal rotation, forward flexion and abduction)
Time Frame: at 6 months
|
clinical assessment of range of movement using goniometer at the shoulder joint
|
at 6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: chris smith, Royal Devon and Exeter
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1312873
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frozen Shoulder
-
Massachusetts General HospitalRecruitingAdhesive Capsulitis | Frozen Shoulder | Shoulder FrozenUnited States
-
University of Sao PauloCompletedShoulder Pain | Frozen Shoulder,Brazil
-
Hospital Durand, ArgentinaRecruitingFrozen Shoulder | Capsulitis, Adhesive | Capsulitis of ShoulderArgentina
-
University of ValenciaCompletedAdhesive Capsulitis of Shoulder | Frozen ShoulderSpain
-
Taipei City HospitalNational Yang Ming Chiao Tung University; National Taiwan University of Science...Not yet recruiting
-
Assiut UniversityNot yet recruiting
-
Chang Gung Memorial HospitalRecruitingFrozen ShoulderTaiwan
-
Tri-Service General HospitalRecruitingFrozen ShoulderTaiwan
-
Tri-Service General HospitalRecruiting
-
Chung Shan Medical UniversityRecruiting
Clinical Trials on arthroscopic capsular release
-
Bergen Surgical HospitalHaukeland University Hospital; Haraldsplass Deaconess HospitalUnknownAdhesive CapsulitisNorway
-
Hospital de Egas MonizHospital de Braga; Centro Hospitalar Lisboa Ocidental; Centro Hospitalar De São... and other collaboratorsWithdrawnRotator Cuff Tear | Graft ComplicationPortugal
-
University of CalgaryCanadian Institutes of Health Research (CIHR); The Arthritis Society, Canada; Smith and Nephew (formerly Oratec Interventions)Completed
-
Akin CilTerminatedAdhesive Capsulitis of the ShoulderUnited States
-
Hawler Medical UniversityCompleted
-
Tartu University HospitalUniversity of TartuNot yet recruitingRotator Cuff Tears | Rotator Cuff Syndrome
-
Chinese University of Hong KongCompletedHallux Valgus | Hallux Valgus and BunionHong Kong
-
Ottawa Hospital Research InstituteRecruiting
-
Ain Shams UniversityActive, not recruiting
-
ZOLCompleted